Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Ozempic, Rybelsus) and chronic weight management (Wegovy)
Deals of the Day Wuka launches the UKs first period-proof swimwear for heavy flows Bridgerton fans are rushing to buy these new Netflix-inspired perfumes now 12 off The affordable summer wardrobe update you'll wear from rooftop drinks to beach holidays The 7.99 lip balm beauty fans love for glossy, hydrated lips just dropped four new shades This Keskine hydrogel mask could fix your summer skin Its harder for them to make an injection to look the same, but its going to be much easier to make pills which look like the real drug than it will be to source all the things for an injection. This article was originally published in June 2026 and has since been updated
Liraglutide was associated with an average loss of 8.4 kilograms over 56 weeks in a major clinical trial
Plant flavonol Quercetin engenders cytotoxic effect in different pre-clinical cancer models through modulation of diverse epigenetic regulators
Looking to do alot - or a little - weve got a plan for you